Bradley Foster & Sargent Inc. CT Has $10.89 Million Position in Cognex Corporation $CGNX

Bradley Foster & Sargent Inc. CT lessened its holdings in shares of Cognex Corporation (NASDAQ:CGNX) by 24.0% in the first quarter, HoldingsChannel.com reports. The firm owned 222,395 shares of the scientific and technical instruments company’s stock after selling 70,196 shares during the period. Bradley Foster & Sargent Inc. CT’s holdings in Cognex were worth $10,895,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of CGNX. Cassaday & Co Wealth Management LLC acquired a new position in shares of Cognex during the first quarter valued at about $36,000. CIBC Private Wealth Group LLC raised its holdings in shares of Cognex by 74.8% in the 3rd quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock worth $35,000 after acquiring an additional 327 shares during the last quarter. Geneos Wealth Management Inc. raised its holdings in shares of Cognex by 402.2% in the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after acquiring an additional 736 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new position in Cognex in the 4th quarter valued at about $39,000. Finally, Larson Financial Group LLC lifted its position in Cognex by 202.7% in the 4th quarter. Larson Financial Group LLC now owns 1,105 shares of the scientific and technical instruments company’s stock valued at $40,000 after acquiring an additional 740 shares in the last quarter. Institutional investors and hedge funds own 88.12% of the company’s stock.

Cognex Stock Performance

Cognex stock opened at $62.05 on Friday. Cognex Corporation has a fifty-two week low of $33.45 and a fifty-two week high of $72.88. The firm’s 50-day simple moving average is $64.97 and its 200 day simple moving average is $55.34. The stock has a market cap of $10.33 billion, a PE ratio of 73.87 and a beta of 1.49.

Cognex (NASDAQ:CGNX) last posted its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.25 by $0.09. Cognex had a net margin of 13.62% and a return on equity of 10.89%. The firm had revenue of $268.44 million during the quarter, compared to analyst estimates of $245.98 million. During the same quarter last year, the business posted $0.14 EPS. The company’s revenue for the quarter was up 24.3% on a year-over-year basis. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. As a group, analysts predict that Cognex Corporation will post 1.48 EPS for the current fiscal year.

Cognex Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 4th. Stockholders of record on Thursday, May 21st were issued a $0.085 dividend. The ex-dividend date of this dividend was Thursday, May 21st. This represents a $0.34 annualized dividend and a dividend yield of 0.5%. Cognex’s dividend payout ratio is currently 40.48%.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. The Goldman Sachs Group reissued a “buy” rating and set a $80.00 price objective (up from $70.00) on shares of Cognex in a report on Monday, May 11th. Zacks Research upgraded Cognex from a “hold” rating to a “strong-buy” rating in a report on Tuesday, June 16th. Robert W. Baird set a $72.00 target price on Cognex in a research report on Friday, May 8th. Seaport Research Partners set a $75.00 target price on Cognex in a research report on Tuesday, May 26th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and set a $75.00 price target on shares of Cognex in a report on Thursday, May 7th. Two investment analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Cognex has a consensus rating of “Moderate Buy” and a consensus price target of $72.31.

Insider Activity at Cognex

In other Cognex news, insider Mark Fennell sold 64,873 shares of the business’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $67.05, for a total value of $4,349,734.65. Following the transaction, the insider owned 11,263 shares of the company’s stock, valued at approximately $755,184.15. The trade was a 85.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Laura Ann Macdonald sold 41,600 shares of the company’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $65.56, for a total value of $2,727,296.00. Following the completion of the transaction, the vice president owned 5,258 shares of the company’s stock, valued at $344,714.48. This trade represents a 88.78% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 224,847 shares of company stock valued at $14,975,098. 1.70% of the stock is owned by insiders.

Cognex Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.